About the Company
We do not have any company description for CareDx, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on CareDx, Inc.
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
CareDx, Inc. (Nasdaq: CDNA) – today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlight ...
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 6, 2025 CareDx, Inc misses on earnings expectations. Reported EPS is $0.1 EPS, ...
What To Expect From CareDx Inc (CDNA) Q2 2025 Earnings
CareDx Inc (NASDAQ:CDNA) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is ...
The Play On CareDx
CareDx focuses on the development and marketing of diagnostic solutions for transplant patients. See why CDNA stock offers a ...
INVESTOR ALERT: CareDx, Inc. Investors with Substantial Losses Have ...
CareDx, Inc., No. 22-cv-03023 (N.D. Cal.). The CareDx class action lawsuit charges CareDx and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
CareDx, Inc (CDNA) Q4 2024 Earnings Call Transcript
CareDx, Inc (NASDAQ: CDNA) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Hanna - President and Chief Executive ...
CareDx to Report Second Quarter 2025 Financial Results
BRISBANE, Calif., July 23, 2025--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value ...
CareDx Breaks Above 200-Day Moving Average - Bullish for CDNA
In trading on Wednesday, shares of CareDx Inc (Symbol: CDNA) crossed above their 200 day moving average of $11.58, changing hands as high as $11.66 per share. CareDx Inc shares are currently ...
CareDx Reports Strong Growth in Testing Services
CareDx Inc ( ($CDNA) ) has released its Q2 earnings. Here is a breakdown of the information CareDx Inc presented to its investors. CareDx, Inc., ...
CareDx Inc. Reports Solid Growth and Raises Guidance - Nasdaq
CareDx, Inc., based in Brisbane, California, is a precision medicine solutions company specializing in the development of healthcare solutions for transplant patients, offering testing services ...
CareDx wins $45 mln verdict against Natera for false advertising
Genetic testing company Natera Inc owes rival CareDx Inc $44.9 million for making false claims about the effectiveness of Natera's Prospera test for assessing the risk that a person's body will ...
CareDx, Inc (CDNA): Among the Best Organ Transplant and Diagnosis ...
CareDx, Inc (NASDAQ:CDNA) is involved in exploring, creating, and marketing diagnostic products for transplant recipients and their caregivers across the United States and globally.
Similar Companies
Loading the latest forecasts...